may lightfoot appointed to the leadership team of the national zantac litigation. 

Products liability firm fights for heartburn medication users

People who take heartburn medication as a means of alleviating discomfort trust in drug companies to put users’ health first. Unfortunately, the results can be life-threatening when manufacturers fail to meet standards, as in the case of the drug Zantac, which is believed to significantly increase the risk of cancer. At May Lightfoot, PLLC in Washington, D.C., we aim to protect the rights of consumers to use an available medication for its intended purpose without the expectation of severe illness or death. If you or a loved one has been diagnosed with cancer after using Zantac or its generic equivalents, we can help you obtain due compensation.

Diligent attorneys evaluate the potentially dangerous effects of Zantac

Zantac, the brand name for the drug ranitidine, is a histamine-2 blocker that reduces the production of stomach acid. On the market since the 1980s as a treatment for heartburn and other gastrointestinal conditions, Zantac has recently been linked to cancer. In 2019, the U.S. Food and Drug Administration (FDA) noted that samples of Zantac tested above acceptable levels of N-nitrosodimethylamine (NDMA), a chemical known to increase the risk of several forms of cancer.

While the FDA continues to investigate Zantac’s potentially harmful effects, a number of victims have alleged that the manufacturers knew about the contaminants in the drugs and failed to warn users of the risks. Manufacturers and distributors of defective products may be held liable for harm caused by the defect even if the company exercised due care in its actions. Our attorneys have the necessary experience and knowledge of products liability law to build a strong case for those injured by treatment with the drug. If you have taken Zantac or a generic equivalent to treat a medical condition and have developed cancer after regular use, we are prepared to take action against all responsible parties and seek justice on your behalf.

Aggressive advocates pursue fair compensation for victims

In April of 2020, the U.S. Food and Drug Administration (FDA) announced that all Zantac brand heartburn drugs, prescription and over-the-counter, should be removed from the market because of potential NDMA contamination, a chemical known to increase the risk of several forms of cancer. 

If you have taken prescription or over-the-counter Zantac and believe that you have developed cancer due to exposure to NDMA contained in the drug, we can assess whether you have a viable claim and bring an action against any potentially liable party. We can then pursue compensation for medical expenses, pain and suffering, loss of wages, and other available damages. Whether through litigation or settlement negotiation, we are committed to helping you recover to the fullest extent for any harm you experienced.

Contact dedicated D.C. products liability attorneys for your Zantac claim

May Lightfoot, PLLC in Washington, D.C. was recently appointed to participate on the leadership team of the Multi-District Litigation by the judge overseeing the federal lawsuits involving Zantac. We will have a key role in the national investigation and discovery involving these cases. We want to represent those individuals who suffer adverse effects after using the drug to treat a medical condition. Call us at (202).506.3591 or contact us at [email protected] to schedule a free initial consultation.